Abstract-The effect of carbon tetrachloride (CCl4) treatment on plasma and liver cytosolic glutathione S-transferase (GST) activities was investigated in rats. CCl4 was intraperitoneally administered at a dose of 0.5 ml/kg. The elevation of plasma GST activity paralleled the increase of plasma glutamate pyruvate transami nase activity after the administration of CCl4. Liver cytosolic GST activities were significantly decreased by CCl4 treatment.
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To establish the relationship of plasma GST with liver cytosolic isozymes, Western blot analysis using antibodies against cytosolic GST 1-2 and 3-4 was performed.
The Western blots showed the exis tence of GST 1-2 and 3-4 in plasma at 24 hr after CCl4 treatment.
The data thus strongly suggest that cytosolic GSTs are lost from the liver to plasma as a con sequence of liver damage.
The Western blot analysis of plasma GST may be useful for monitoring liver damage.
The glutathione S-transferases (GST; EC 2.5.1.18) are a family of multifunctional pro teins involved in xenobiotics metabolism (1) . These enzymes are the most abundant in the liver, comprising 5 to 10% of the soluble hepatic proteins (2) . The treatment of rats with carbon tetrachloride (CCI4), a well known hepatotoxic chemical, has been shown to cause the decrease of hepatic cytosolic GST activity (3). CC14 induced hepatotoxicity would be also accompanied by an elevation of serum GST activity as well as an increase in serum glutamate-pyruvate transaminase ac tivity (3) .
Multiple forms of GST have recently been identified in various organs such as the liver , and so more definitive information on the source of the serum GST activity will be necessary; however, this still remains to be clarified. In the present study, we examined the alteration of hepatic cytosolic and plasma GST activity in CCI4-poisoned rats and also describe the relationship of plasma GST(s) with hepatic cytosolic GST isozymes by im munoblotting.
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Materials and Methods
Animal treatment: Seven week-old male Sprague Dawley rats were used. CC14 diluted with corn oil was administered to the rats (0.5 ml/kg, i.p.). Control animals received an equivalent volume of corn oil alone. All rats were fasted for 24 hr before CCI4 adminis tration. Blood was collected under ether an esthesia from the abdominal aorta and cen trifuged at 3,000 rpm for 10 min at 4°C, and then the plasma was separated. The livers were quickly removed and 20% (W/V) homogenates were prepared. The homo genate was centrifuged at 105,000 x g for 60 min. The resulting clear supernatant after the removal of the lipid layer at the top of the centrifuge tubes was used as the cytosol for all assays. Assays: G Iutamate pyruvate-transami nase (GPT) present in the plasma was determined using commercial assay kits of latron K.K. (Tokyo, Japan). GST activity was measured by the method of Habig et al. Protein was determined by the procedure of Lowry et al. (5) with bovine serum albumin as a standard.
Chemicals: 1-Chloro-2,4-dinitrobenzene (CDNB), 1,2-dichloro-4-nitrobenzene (DCNB), trans-phenylbuten-3-one (t-PBO) and CC14 were purchased from Wako Pure Chemical Industries, Ltd. (Tokyo, Japan). All other reagents used were of analytical grade.
Purification of GST and antibody produc tion: The hepatic cytosol from male rats was dialyzed against 10 mM Tris-HCI (pH 8.0). The dialysate was applied onto an S-hexyl glutathione-affinity column, which was pre pared from epoxy-activated Sepharose 6B (Pharmacia Fine Chemicals) according to the method of Mannervik and Guthenberg (6) . GST is eluted with 10 mM Tris-HCI-0.2 M NaCI (pH 8.0) containing 5 mM S-hexylglu tathione. The eluates were pooled and con centrated to a small volume by ultrafiltration with a Diaflo PM-10 membrane, and then charged onto a column of Sephadex G-25 to remove S-hexylglutathlone. The thus purified GSTs showed three distinct bands of GST subunits, Ya (1), Yb1 (3)/Yb2 (4) and Yc (2), on SDS-polyacrylamide gel electrophoresis, in which Yb1 (3) and Yb2 (4) subunits migrated to the same position.
The purification of GST 1-2 and 3-4 isozymes and their antibody production were carried out as described previously (7).
Immunotitration of plasma GST activity: The activity inhibition test with anti GST 1-2 and 3-4 antibodies was performed as fol lows: Twenty to 300 ,ul portions of the antisera were added to 0.05 ml of CC14 treated rat plasma (GST activity to CDNB, 2.41 U/ ml), and the final volume was brought up to 0.35 ml with 10 mM sodium phosphate-0.9% NaCI (pH 7.4). The mixtures were left over night at 4 °C and then centrifuged at 10,000 x g for 5 min. The resulting supernatant was used for assaying GST activity towards CDNB. The degree of inhibition of the activity by each antibody was expressed as a percentage of the control activity using nonimmune control serum.
Western blot analysis: Western blots were performed as described by Towbin et al. (8) with slight modifications.
After electropho resis in a slab containing 12.5% SDS polyacrylamide as described by Laemmli (9) al of 30% H202 in 80 ml of 50 mM Tris-HCI (pH 7.6).
Results
The time course of plasma GPT and GST activities after CC14 treatment is illustrated in Fig. 1 Western blot analyses using antibodies against GST 1-2 and 3-4 were carried out to determine which isozymes were decreased in the cytosol and expressed in the plasma during CC14 treatment (Fig. 3) . Results showed that anti GST 1-2 antiserum did not cross-react with the Yb1 (3) and Yb2 (4) subunits, and that anti GST 3-4 antiserum did not react with the Yc (2) subunit, while it reacted with the Ya (1) Fig. 4 , the GST activity of CC14 treated rat plasma was inhibited by im munotitration with anti GST 1-2 and 3-4
antiserum. It was also found that plasma GST activity after CC14 treatment was pre cipitated to a much greater extent by anti GST 3-4 than 1-2 antiserum. (10) demonstrated that the plasma level of ligandin, one of the GST isozymes, rose greatly in CC14-treated rats by using the radioimmunoassay for ligandin, suggesting that plasma ligandin is a sensitive index of experimental hepatocellular necrosis. Later, ligandin has been identified as a dimer composed of the Ya (1) subunit and iden tical with GST 1-1 (11). Beckett and Hayes (12) have also used the radioimmunoassay for estimating plasma GST level and demon strated that the increase of plasma concen trations of GST YaYa (also named GST 1-1) occurred by the administration of hepatotoxic drugs including paracetamol, halothane, tri iodothyronine and so on. Recently, it has been shown that hepatic cytosolic major GSTs are composed of various pairs of four distinct subunits: Ya (1), Yc (2), Yb1 (3) and Yb2 (4), on the basis of immunological properties and substrate specificities (13, 14) . Mannervik and Jensson (13) indicated that the six major transferases (GST 1-1, 1-2, 2-2, 3-3, 3-4 and 4-4) in rat hepatic cytosol can be clas sified into two groups, 1-2 and 3-4. CDNB is generally a good substrate for all isozymes of GSTs, but DCNB and t-PBO are active for only isozymes having subunit 3 and 4, re spectively (15) . The decrease of cytosolic GST activities towards DCNB and t-PBO as well as CDNB suggests that not only GST 1-2 but 3-4 isozymes may be altered by CC14 treatment. These alteration in GST isozymic 
